Log in here
Top Journalists
>
Jason Laday

Jason Laday

Author at healio.com at Healio

Contact this person
Email address
j*****@*******.comGet email address
Influence score
36
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to AI PR

    View latest data and reach out all from one place
    Sign up to AI PR Toolkit

    Recent Articles

    healio.com

    New England Journal of Medicine retracts avacopan study used by FDA to assess efficacy

    The New England Journal of Medicine has retracted its publication of the sole trial of avacopan used by the FDA to assess the drug’s efficacy before approving it for patients with ANCA-associated vasculitis.The retraction comes amid the FDA’s push to withdraw its approval of avacopan (Tavneos, Amgen), alleging that employees of the original manufacturer, ChemoCentryx, manipulated data
    3 months ago
    healio.com

    FDA grants breakthrough designation to ianalumab for Sjögren’s disease

    The FDA has granted breakthrough therapy designation to Novartis’ ianalumab for Sjögren’s disease, according to a press release from the manufacturer.In its statement, Novartis said it plans to submit ianalumab — a fully human monoclonal antibody that features a novel dual mechanism of action, which depletes B cells and inhibits their activation and survival via BAFF-R blockade
    9 months ago
    healio.com

    Research illuminating ‘powerful regulators of the immune system’ wi...

    The 2025 Nobel Prize in Physiology or Medicine has been awarded to a trio of researchers whose work identified and shed light on regulatory T cells and how they prevent the immune system from attacking the body. Mary E. Brunkow, PhD, of the Institute for Systems Biology, in Seattle, Fred Ramsdell, PhD, of Sonoma Biotherapeutics, in San Francisco, and Shimon Sakaguchi, MD, PhD, of Osaka
    about 1 year ago
    healio.com

    Chronic pain too complex for ‘linear’ strategy, requires physical a...

    HUNTINGTON BEACH, Calif. — Chronic pain is too complex for “linear” approaches and instead requires an interdisciplinary focus on behavioral and physical health, said a presenter at the 2025 Congress of Clinical Rheumatology West.“As rheumatologists, you are acutely aware that your patients come in very complex — no simple patient comes into rheumatology, or pain
    about 1 year ago
    healio.com

    Transcranial stimulation alongside exercise, education improves fib...

    Anodal transcranial direct current stimulation, combined with exercise and patient education, is superior to placebo for improving fibromyalgia pain interference, according to data published in JAMA Network Open.“This study addressed key limitations of previous trials, such as small sample sizes, short follow-up periods, and lack of control for placebo effects,” Wolnei Caumo, MD, PhD,
    about 1 year ago
    healio.com

    AI’s ubiquity in health care, use at point of care ‘no longer a dis...

    AI has within the last few years burgeoned into a ubiquitous presence in physician offices and medical facilities across multiple specialties, including rheumatology.And while its most common uses still appear to be in coding, letter writing and transcribing, AI has also been gaining ground — and utility — at the point of care.
    about 1 year ago
    healio.com

    Healio Rheumatology wins APEX Grand Award for story on physician wo...

    Healio Rheumatology senior staff writer Rob Volansky has won an APEX Grand Award for Writing/Topics, for the cover story, “‘We cannot pour from an empty cup:’ Work-life balance takes priority for today’s providers.”The Healio Exclusive, available here, appeared in the April 2024 issue of Healio Rheumatology. The APEX Awards for Publication Excellence recognize
    about 1 year ago
    healio.com

    Women accounted for fewer than 40% of rheumatology clinical trial a...

    A review of randomized clinical trials published in rheumatology from 2009 to 2023 found that just 39.8% of authors were women, and that women were less likely to be senior authors, according to data published in RMD Open.“In recent years, there has been some progress in narrowing the gender publication gap, but the pace of improvement has shown signs of deceleration, particularly
    over 1 year ago
    healio.com

    FDA expands Jylamvo approval to include polyarticular juvenile idio...

    The FDA has expanded the approval of an oral liquid methotrexate solution to include children and adolescents with polyarticular juvenile idiopathic arthritis and acute lymphoblastic leukemia, according to a press release.The FDA’s decision marks Jylamvo (methotrexate, Shorla Oncology) as the only oral liquid form of methotrexate approved for both adult and pediatric indications currently
    almost 2 years ago
    healio.com

    FDA OKs Bimzelx for psoriatic arthritis, ankylosing spondylitis, no...

    The FDA has expanded the indication of Bimzelx to include psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis with objective signs of inflammation, according to a press release.The approvals apply to adults with active disease. The drug had previously been approved for moderate-to-severe plaque psoriasis in October 2023. According to the release from the
    about 2 years ago
    healio.com

    Obstetric outcomes unaffected by maintaining TNF inhibition during ...

    SAN DIEGO — In patients with chronic rheumatic inflammatory disease, those who continue TNF inhibition during pregnancy have similar obstetrical outcomes as those who cease treatment, according to data presented at ACR Convergence 2023.Moreover, pregnant patients who maintained their use of TNF inhibitors experienced fewer severe maternal infections vs. those who stopped, the researchers
    almost 3 years ago